Document is current
Any future updates will be listed below
-
Authors
Shen, Steven
Mohan, Aditya A https://orcid.org/0000-0001-7614-9387
Hotchkiss, Kelly M
Cook, Sarah https://orcid.org/0000-0002-0516-9388
Patel, Kisha
Moelker, Eliese
Puviindran, Bhairavy
Gonzalez, Ariel T
Zaidi, Saif
Spellicy, Samantha
Schwartz, Adam
Suryadevara, Carter
Wilkinson, Daniel
Ayasoufi, Katayoun https://orcid.org/0000-0002-3797-0823
Fecci, Peter E
Sanchez-Perez, Luis
Sampson, John
Patel, Anoop
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05095441 at ClinicalTrials.govnct02062827 at ClinicalTrials.govDocuments that mention this clinical trial
IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma
https://doi.org/10.1136/jitc-2025-012532
Documents that mention this clinical trial
IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma
https://doi.org/10.1136/jitc-2025-012532
Advances in the management of glioblastoma
https://doi.org/10.1136/jnnp-2020-325334
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
https://doi.org/10.1136/jitc-2023-008025
-
Funding
Funding for this research was provided by:
Dexter Lu Research Fund (Preston Robert Tisch Brain Tumor Center 2910683)
- License Information
